MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outpatient and home settings; MindMotion Companion, an application that manages prescription, monitoring and documentation across MindMaze Therapeutics' neurotherapeutics ecosystem; and the patient app, a patient-facing mobile application, that supports clinic-to-home continuity by making prescribed therapy easy to follow outside the clinic. It also provides Izar hand therapy device which supports fine motor rehabilitation; Physilog sensor, a wearable inertial sensing device designed to quantify human movement; toaprun, a training for Parkinson's therapy-reimagined through play. The company was founded in 2012 and is headquartered in Geneva, Switzerland.
Frequently asked questions
What sector does Relief Therapeutics Holding AG (RLFTY) operate in?
Relief Therapeutics Holding AG belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Relief Therapeutics Holding AG (RLFTY) current stock price?
As of the latest data, Relief Therapeutics Holding AG stock price is $0.18, with a previous close of $0.18.
What is Relief Therapeutics Holding AG (RLFTY) current market capitalization?
Relief Therapeutics Holding AG market cap is approximately 30.24 million.
What is Relief Therapeutics Holding AG (RLFTY) Earnings Per Share (EPS)?
The trailing EPS is -$0.29.
Does Relief Therapeutics Holding AG (RLFTY) pay dividends?
No. Relief Therapeutics Holding AG does not pay a dividend.
What is Relief Therapeutics Holding AG (RLFTY) beta (volatility) score?
Relief Therapeutics Holding AG has a beta of -0.325, indicating lower volatility than the overall market.
